Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.35 |
| ▸ | AKT1 | P31749 | 2/20 | 0.30 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.30 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.30 |
| ▸ | AKT2 | P31751 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.30 |
| ▸ | GAB1 | Q13480 | 1/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25077088 | 0.91 | POLRMT (0.39) | POLRMTAKT1PLCG2PIK3R1AKT2 | |
| SCHEMBL25077037 | 0.91 | POLRMT (0.34) | POLRMT | |
| SCHEMBL25077189 | 0.90 | POLRMT (0.32) | POLRMTS1PR1 | |
| SCHEMBL25077065 | 0.89 | POLRMT (0.33) | POLRMTAKT1PLCG2PIK3R1AKT2 | |
| SCHEMBL25076958 | 0.89 | POLRMT (0.36) | POLRMTAKT1PLCG2PIK3R1AKT2 | |
| SCHEMBL25077324 | 0.89 | POLRMT (0.39) | POLRMTS1PR1 | |
| SCHEMBL25076954 | 0.88 | POLRMT (0.39) | POLRMTAKT1PLCG2PIK3R1AKT2 | |
| SCHEMBL25077634 | 0.87 | POLRMT (0.33) | POLRMTAKT1PLCG2PIK3R1AKT2 | |
| SCHEMBL25766796 | 0.87 | POLRMT (0.32) | POLRMT | |
| SCHEMBL25077536 | 0.86 | POLRMT (0.33) | POLRMTAKT1PLCG2PIK3R1AKT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023023527-A1 | PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2023-02-23 | — | — | WO | disclosed |